NEUROMYELITIS OPTICA side effect
What is NEUROMYELITIS OPTICA ?NEUROMYELITIS OPTICA : Tysabri Side Effects Report #5651837-2
Consumer or non-health professional from UNITED STATES reported TYSABRI problem on Feb 19, 2008. Female patient, 54 years of age, weighting 167.0 lb, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, . TYSABRI dosage: 300 MG;QM;IV. Patient was hospitalized. Patient recovered.
NEUROMYELITIS OPTICA : Tysabri Side Effects Report #5691292-X
TYSABRI problem was reported by a Physician from UNITED STATES on Mar 18, 2008. Female patient was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, . TYSABRI dosage: 300 MG;QM;IV. During the same period patient was treated with AVONEX. Patient recovered.
NEUROMYELITIS OPTICA : Tysabri Side Effects Report #5621672-X
Physician from UNITED STATES reported TYSABRI problem on Jan 21, 2008. Female patient was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, . TYSABRI dosage: 300 MG;QM;IV. During the same period patient was treated with AVONEX. Patient recovered.
NEUROMYELITIS OPTICA : Rebif Side Effects Report #5643967-6
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 13, 2008. Male patient, 42 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.
NEUROMYELITIS OPTICA : Rebif Side Effects Report #5575268-9
Consumer or non-health professional from UNITED STATES reported REBIF problem on Dec 18, 2007. Female patient, 48 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, respiratory failure, . REBIF dosage: unknown. Patient died on 04/16/2007.
NEUROMYELITIS OPTICA : Rebif Side Effects Report #5465316-9
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 10, 2007. Female patient, 55 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.
NEUROMYELITIS OPTICA : Natalizumab Side Effects Report #5470301-7
Health Professional from UNITED STATES reported NATALIZUMAB problem on Sept 10, 2007. Female patient, 29 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, . NATALIZUMAB dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.
NEUROMYELITIS OPTICA : Strattera Side Effects Report #5383353-X
STRATTERA problem was reported by a Physician from IRELAND on June 27, 2007. Male patient, 16 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, . STRATTERA dosage: 25 MG, DAILY (1/D). During the same period patient was treated with CONCERTA. Patient was hospitalized. Patient recovered.
NEUROMYELITIS OPTICA : Strattera Side Effects Report #5388422-6
Physician from IRELAND reported STRATTERA problem on July 03, 2007. Male patient, 16 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, vertebral column mass, . STRATTERA dosage: 25 MG, DAILY (1/D). During the same period patient was treated with CONCERTA. Patient was hospitalized. Patient recovered.
NEUROMYELITIS OPTICA : Strattera Side Effects Report #5383353-X
STRATTERA problem was reported by a Physician from IRELAND on June 27, 2007. Male patient, 16 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, . STRATTERA dosage: 25 MG, DAILY (1/D). During the same period patient was treated with CONCERTA. Patient was hospitalized. Patient recovered.
NEUROMYELITIS OPTICA : Strattera Side Effects Report #5388422-6
Physician from IRELAND reported STRATTERA problem on July 03, 2007. Male patient, 16 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, vertebral column mass, . STRATTERA dosage: 25 MG, DAILY (1/D). During the same period patient was treated with CONCERTA. Patient was hospitalized. Patient recovered.
NEUROMYELITIS OPTICA : Rebif Side Effects Report #5678695-4
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 11, 2008. Male patient, 24 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, . REBIF dosage: unknown. During the same period patient was treated with ADVAIR, ALBUTEROL INHALER. Patient was hospitalized. Patient recovered.
NEUROMYELITIS OPTICA : Avonex Side Effects Report #5680981-9
Consumer or non-health professional from UNITED STATES reported AVONEX problem on Mar 13, 2008. Female patient, 25 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: dyspnoea, neuromyelitis optica, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
NEUROMYELITIS OPTICA : Tysabri Side Effects Report #5606900-9
TYSABRI problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 18, 2008. Female patient, 33 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: multiple sclerosis, neuromyelitis optica, quadriplegia, rash, refusal of treatment by patient, urinary retention, urinary tract infection, urticaria, . TYSABRI dosage: 300 MG; QM; IV. Patient was hospitalized. Patient died on 12/30/2005.
NEUROMYELITIS OPTICA : Tysabri Side Effects Report #5607488-9
Consumer or non-health professional from UNITED STATES reported TYSABRI problem on Jan 18, 2008. Female patient, 33 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: multiple sclerosis, neuromyelitis optica, paralysis, . TYSABRI dosage: unknown. During the same period patient was treated with REBIF. Patient was hospitalized. Patient died on 12/30/2005.
NEUROMYELITIS OPTICA : Natalizumab Side Effects Report #5549561-X
NATALIZUMAB problem was reported by a Health Professional from UNITED STATES on Nov 30, 2007. Female patient, 63 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: multiple sclerosis relapse, neuromyelitis optica, no therapeutic response, pneumonia, urinary tract infection, . NATALIZUMAB dosage: 300 MG; QM; IV. During the same period patient was treated with LEVOXYL, BONIVA, AMBIEN, NOVANTRONE. Patient was hospitalized. Patient died on 07/01/2007.
NEUROMYELITIS OPTICA : Natalizumab Side Effects Report #5523132-3
Consumer or non-health professional from UNITED STATES reported NATALIZUMAB problem on Nov 12, 2007. Female patient, 58 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: delirium, neuromyelitis optica, . NATALIZUMAB dosage: 300 MG; QM; IV. During the same period patient was treated with AVONEX. Patient was hospitalized. Patient died on 01/01/2007.
NEUROMYELITIS OPTICA : Tysabri Side Effects Report #5483831-9
TYSABRI problem was reported by a Health Professional from UNITED STATES on Oct 02, 2007. Female patient, 29 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: myelitis, neuromyelitis optica, . TYSABRI dosage: 300 MG;QM; IV. Patient was hospitalized. Patient recovered.
NEUROMYELITIS OPTICA : Natalizumab Side Effects Report #5493908-X
Physician from UNITED STATES reported NATALIZUMAB problem on Oct 10, 2007. Female patient, 40 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: multiple sclerosis relapse, neuromyelitis optica, paraparesis, . NATALIZUMAB dosage: 300 MG;QM;IV. During the same period patient was treated with AVONEX. Patient was hospitalized. Patient recovered.
NEUROMYELITIS OPTICA : Avonex Side Effects Report #5392973-8
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on July 09, 2007. Female patient, 43 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: multiple sclerosis relapse, neuromyelitis optica, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
NEUROMYELITIS OPTICA : Avonex Side Effects Report #5392973-8
Consumer or non-health professional from UNITED STATES reported AVONEX problem on July 09, 2007. Female patient, 43 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: multiple sclerosis relapse, neuromyelitis optica, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.